FDA approves Xgeva for the treatment of giant cell tumor of bone
Amgen has announced that the FDA ( Food and Drug Administration ) has approved a new indication for Xgeva ( Denosumab ) for the treatment of adults and skeletally mature adolescents with giant cell tu ...
read article